The Effect of Voltaren-ophtha 0.1% Eye Drops on INR Levels (International Normalized Ratio) in Patients Taking Warfarin
NCT02782338 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2016-06-01
Summary
A prospective study intended to examine the effect of topical Voltaren-Ophtha 0.1% eye drops after cataract surgery on INR levels (international normalized ratio) in patients taking warfarin.
Conditions
- Blood Coagulation Disorders
Interventions
- DRUG
-
Voltaren ophtha 0.1%
All study patients will be treated with Voltaren ophtha 0.1% after cataract surgery
Sponsors & Collaborators
-
Wolfson Medical Center
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-05-31
- Primary Completion
- 2017-05-31
- Completion
- 2017-12-31
More Related Trials
-
In Clinic Optometrist Insertion of Dextenza Prior to Cataract Surgery
NCT05023304 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery
NCT00524264 ·Status: COMPLETED ·Phase: PHASE3
-
Time Serial Analysis on Preemptive Analgesia of Preoperative Topical Diclofenac and Ketorolac in Photorefractive Keratectomy(PRK)
NCT01761071 ·Status: COMPLETED ·Phase: PHASE3
-
Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients
NCT00347503 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparison of 0.5% Loteprednol Etabonate Versus 1% Prednisolone Acetate Following Cataract Surgery
NCT01384266 ·Status: COMPLETED
-
DEXTENZA Compared to Topical Steroid Therapy Prior to Cataract Surgery in Patients Who Receive Premium Intraocular Lenses
NCT04479748 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Study to Assess the Efficacy and Safety of Dexamethasone Suspension for Cataract Surgery
NCT03687931 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Prophylactic Nepafenac and Ketorolac Versus Placebo in Patients Undergoing Cataract Surgery
NCT01395069 ·Status: COMPLETED ·Phase: PHASE4
-
Taurine Eye Drops May Prevent the Progression of Cataract
NCT06639711 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Diclofenac vs Dexamethasone in Combined Surgery
NCT00825864 ·Status: COMPLETED ·Phase: NA
-
Ketorolac Levels in Vitreous and Aqueous Samples From Patients Undergoing Combined Cataract and Pars Plana Vitrectomy Surgeries With and Without Intracameral Phenylephrine 1.0% / Ketorolac 0.3%
NCT06539637 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Study to Compare Ocular Safety and Tolerability of Eye Drops Containing Prednisolone Acetate in Patients With Intraocular Inflammation After Cataract Surgery
NCT00170729 ·Status: COMPLETED ·Phase: PHASE4
-
Anti-inflammatory Therapy Following Selective Laser Trabeculoplasty
NCT00485108 ·Status: COMPLETED ·Phase: NA
-
Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery
NCT00645671 ·Status: COMPLETED ·Phase: PHASE3
-
The Use of Sublingual Melatonin Premedication in Geriatric Cataract Surgery
NCT07036367 ·Status: RECRUITING ·Phase: PHASE4
-
Study for Optimizing Anti-inflammatory Prophylaxis
NCT03383328 ·Status: COMPLETED ·Phase: PHASE4
-
Fluorophotometry Evaluation of Lubricant Eye Drops
NCT00347854 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery
NCT04739709 ·Status: COMPLETED ·Phase: PHASE3
-
Eye Surface Properties After Using Dexamethasone Drops With and Without Preservatives in Patients After Cataract Surgery
NCT05753787 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Effect of Ophthalmic Solutions on Contact Lenses Used After Surgery for Congenital Cataract Investigated in Vivo
NCT03125785 ·Status: UNKNOWN
-
Efficacy and Safety of RX-10045 Ophthalmic Solution for Ocular Inflammation and Pain in Cataract Surgery
NCT02329743 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Ketorolac 0.4% in Prostaglandin Suppression
NCT00791323 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparison of Post Phacoemulsification Aqueous Flare in Patients Using Ketorolac 0.45% 2 Times Daily (BID) and Bromfenac 0.09% 2 Times Daily (BID)
NCT01023724 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOC
NCT06681688 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Effect of Prophylactic Ketorolac on CME After Cataract Surgery
NCT00335439 ·Status: COMPLETED ·Phase: NA